Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Korean Diabetes Journal
>
2008
>
32
>
6
Volume:
32
Issue:
6
1. The Classification of Diabetic Patients Presenting Diabetic Ketoacidosis: The Characteristics of Fulminant Type 1 Diabetes.
Page:537—538
2. The Classification of Diabetic Patients Presenting Diabetic Ketoacidosis: The Characteristics of Fulminant Type 1 Diabetes.
Page:534—536
3. The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus.
Page:532—533
4. Maintenance of Insulin Therapy by Desensitization in Insulin Allergy Patient.
Page:529—531
5. The Changes of Central Aortic Pulse Wave Analysis in Metabolic Syndrome.
Page:522—528
6. Effect of Valsartan on Blood Pressure and Urinary Albumin Excretion in Hypertensive Type 2 Diabetic Patients: An Open-Label, Multicenter Study.
Page:513—521
7. The Efficacy of Fixed Dose Rosiglitazone and Metformin Combination Therapy in Poorly Controlled Subjects with Type 2 Diabetes Mellitus.
Page:506—512
8. Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Future Risk of Diabetes Mellitus in Korean Men.
Page:498—505
9. Cystatin C is a Valuable Marker for Predicting Future Cardiovascular Diseases in Type 2 Diabetic Patients.
Page:488—497
10. Protective Effects of Glucagon Like Peptide-1 on HIT-T15 beta Cell Apoptosis via ER Stress Induced by 2-deoxy-D-glucose.
Page:477—487
11. Cystatin C is a Valuable Marker for Predicting Future Cardiovascular Diseases in Type 2 Diabetic Patients.
Page:474—476
12. Mitochondrial Dysfunction in Diabetic Cardiomyopathy.
Page:467—473
